What makes an mRNA vaccine so effective against severe COVID-19?

Washington University ICTS vaccine
Washington University in St. Louis student Julian McCall receives a dose of Pfizer’s mRNA-based COVID-19 vaccine. A new study by researchers at Washington University School of Medicine in St. Louis and St. Jude Children’s Research Hospital helps explain w
Image Credit
Matt Miller, Washington University School of Medicine

Shots trigger exceptional antibody response by activating key helper immune cells

CTSA Program In Action Goals
Goal 2: Engage Patients and Communities in Every Phase of the Translational Process
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan
Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
Goal 5: Advance the Use of Cutting-Edge Informatics